Example: Heart Attack

Search clinical trials for: Antifungal Agents

Total 3133 results

NCT01524432

Completed

Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis

Conditions: Tinea Pedis
NCT04502771

Completed

Therapeutic Drug Monitoring of Antifungals in Intensive Care Units

Conditions: Intensive Care Unit Patients
NCT01686607

Completed

Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents

Conditions: Systemic Fungal Infections
NCT03117439

Completed

Beta-Glucan Driven vs. Empirical Antifungal Therapy in Critically Ill Patients

Conditions: Antifungal Agents
NCT04341402

Recruiting

Systemic Uptake of Diclofenac Sodium in Combination With Miconazole as Antifungal Nail Gel When Applied Daily With Monitoring of Hepatic and Renal Enzymes, and Serum Levels of Diclofenac 12 Hours After Application, and at 3 and 6 Months Study

Conditions: Tinea Unguium, Onychomycosis
NCT00386802

Completed

Antifungal Use in Oncohematological Neutropenic Patients

Conditions: Invader Fungal Infection
NCT01869829

Completed

PEACE: Pediatric Antifungal Comparative Effectiveness

Conditions: Pediatric Invasive Candidiasis
NCT00936910

Completed

Antifungal Locks to Treat Fungal-related Central Line Infections

Conditions: Central Line Fungal Infections
NCT03333005

Completed

Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia

Conditions: Acute Myeloid Leukemia
NCT04004078

Recruiting

An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDM

Conditions: Invasive Fungal Infection
NCT04680884

Not yet recruiting

Empirical Steroids and/or Antifungals in Immunocompromised Patients With Acute Respiratory Failure From Undetermined Etiology: a Multicenter Double-blind Randomized Controlled Trial

Conditions: Acute Respiratory Failure; Immunocompromised Patients
NCT02900430

Completed

Invasives Aspergillosis in Acute Myeloid Leukemia

Conditions: Acute Myeloid Leukemia; Invasive Aspergillosis
NCT00906633

Completed

Seifem Surveillance of Antifungal Combination Therapy In Hematologic Italian Centers

Conditions: Fungal Infection
NCT00982540

Terminated

Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients

Conditions: Invasive Fungal Infections; Invasive Aspergillosis; Invasive Fusariosis
NCT00934934

Terminated

Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment

Conditions: Ventilator Associated Pneumonia; Respiratory Tract Infection
NCT01288378

Completed

Empirical Versus Preemptive Antifungal Therapy

Conditions: Fungal Infection; Leukemia; Myelodysplastic Syndromes
NCT02321098

Completed

Antifungal Activity of Loceryl Nail Lacquer in Combination With a Cosmetic Varnish

Conditions: Foot Dermatoses
NCT02057289

Terminated

A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis

Conditions: Immunocompromised; Bone Marrow Transplant; Cancer
NCT03090334

Recruiting

A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis

Conditions: Invasive Candidiases; Abdominal Infection
NCT00253305

Completed

Topical Gel Anti-Fungal Agent for Tinea Unguium

Conditions: Onychomycosis
NCT02366884

Recruiting

Clinical Evaluation of a New Form of Cancer Therapy Based on the Principles of Atavistic Metamorphosis (Atavistic Chemotherapy).

Conditions: Neoplasms
NCT04531540

Completed

Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)

Conditions: Hypersensitivity
NCT04531813

Completed

Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test)

Conditions: Hypersensitivity
NCT04531527

Completed

Study to Learn More About the Potential of Antifungal Cream V61-044 Containing Trolamine to Cause Irritant Reaction of the Skin to Ultra Violet Light in Healthy Human Subjects

Conditions: Dermatitis, Phototoxic
NCT03819348

Unknown status

Retrospective Analysis of the Epidemiological Change and Determinants of Prognosis of Talaromycosisof Human Immunodeficiency Virus Negative Host in Guangxi

Conditions: To Investigate the Characteristics and Prognostic Factors of T. Marneffei Infections and the Causes of Misdiagnosis; To Study the Recurrence Indicators and Establish a Therapeutic Effect Evaluation System of T. Marneffei Infections